Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.
Sonavex has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Sonavex's investors include National Science Foundation, Gaingels, TEDCO, Fusion Fund, National Institutes of Health.
Sonavex is headquartered in Baltimore, United States.
Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.
Sonavex is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sonavex — Funding & Investors." VCBacked, October 24, 2024, https://www.vcbacked.co/company/sonavex. Accessed July 19, 2026.
VCBacked. (2024). Sonavex — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/sonavex
{{cite web |title=Sonavex — Funding & Investors |url=https://www.vcbacked.co/company/sonavex |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated